SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-10-053187
Filing Date
2010-10-21
Accepted
2010-10-21 17:27:34
Documents
16
Period of Report
2010-10-21
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a10-19776_18k.htm 8-K 26646
2 EX-99.1 a10-19776_1ex99d1.htm EX-99.1 22824
3 EX-99.2 a10-19776_1ex99d2.htm EX-99.2 23472
4 GRAPHIC g197761moi001.gif GRAPHIC 103043
5 GRAPHIC g197761moi002.gif GRAPHIC 180529
6 GRAPHIC g197761moi003.gif GRAPHIC 91111
7 GRAPHIC g197761moi004.gif GRAPHIC 109342
8 GRAPHIC g197761moi005.gif GRAPHIC 78566
9 GRAPHIC g197761moi006.gif GRAPHIC 96534
10 GRAPHIC g197761moi007.gif GRAPHIC 70958
11 GRAPHIC g197761moi008.gif GRAPHIC 86004
12 GRAPHIC g197761moi009.jpg GRAPHIC 48477
13 GRAPHIC g197761moi010.jpg GRAPHIC 55075
14 GRAPHIC g197761moi011.gif GRAPHIC 65484
15 GRAPHIC g197761moi012.gif GRAPHIC 89089
16 GRAPHIC g197761mmi001.gif GRAPHIC 5356
  Complete submission text file 0001104659-10-053187.txt   1563877
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 101135714
SIC: 2834 Pharmaceutical Preparations